Blood raising mixture suitable for yin-blood deficiency and heat-poison accumulation and binding type pancytopenia after radiotherapy and chemotherapy or targeted therapy
The invention discloses a blood raising mixture suitable for yin-blood deficiency and heat-poison accumulation and binding type pancytopenia after radiotherapy and chemotherapy or targeted therapy. The blood raising mixture is prepared from the following components in parts by weight: 10-40 parts of raw radix rehmanniae, 10-40 parts of prepared rehmannia rhizome, 5-20 parts of radix asparagi, 10-30 parts of rhizoma dioscoreae, 10-40 parts of radix scrophulariae, 10-40 parts of radix pseudostellariae, 20-50 parts of gypsum, 5-20 parts of rhizoma anemarrhenae, 1-5 parts of rhizoma curcumae, 1-5parts of rhizoma sparganii, 4-16 parts of colla carapacis et plastri testudinis, 5-20 parts of stir-fried fructus arctii, 5-20 parts of stir-fried rhizoma atractylodis macrocephalae, 5-20 parts of radix angelicae sinensis and 4-16 parts of radix glycyrrhizae preparata. By clinical application, practices show that the prescription has remarkable improvement effect on yin-blood deficiency and heat-poison accumulation and binding type pancytopenia such as leukocyte, erythrocyte and thrombocyte, has positive effect of assisting patients in successful completion of radiotherapy and chemotherapy andtargeted therapy, has significant relief effect on symptoms of fatigue, xerostomia and the like, and can improve life quality of patients..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Europäisches Patentamt - (2020) vom: 15. Sept. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
LIU YONG [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-09-15, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 |
---|
Patentnummer: |
CN111658747 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA006560105 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA006560105 | ||
003 | DE-627 | ||
005 | 20230504115728.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA006560105 | ||
035 | |a (EPA)CN111658747 | ||
035 | |a (EPA)72392611 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a LIU YONG |e verfasserin |4 aut | |
245 | 1 | 0 | |a Blood raising mixture suitable for yin-blood deficiency and heat-poison accumulation and binding type pancytopenia after radiotherapy and chemotherapy or targeted therapy |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2020-09-15, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 | ||
520 | |a The invention discloses a blood raising mixture suitable for yin-blood deficiency and heat-poison accumulation and binding type pancytopenia after radiotherapy and chemotherapy or targeted therapy. The blood raising mixture is prepared from the following components in parts by weight: 10-40 parts of raw radix rehmanniae, 10-40 parts of prepared rehmannia rhizome, 5-20 parts of radix asparagi, 10-30 parts of rhizoma dioscoreae, 10-40 parts of radix scrophulariae, 10-40 parts of radix pseudostellariae, 20-50 parts of gypsum, 5-20 parts of rhizoma anemarrhenae, 1-5 parts of rhizoma curcumae, 1-5parts of rhizoma sparganii, 4-16 parts of colla carapacis et plastri testudinis, 5-20 parts of stir-fried fructus arctii, 5-20 parts of stir-fried rhizoma atractylodis macrocephalae, 5-20 parts of radix angelicae sinensis and 4-16 parts of radix glycyrrhizae preparata. By clinical application, practices show that the prescription has remarkable improvement effect on yin-blood deficiency and heat-poison accumulation and binding type pancytopenia such as leukocyte, erythrocyte and thrombocyte, has positive effect of assisting patients in successful completion of radiotherapy and chemotherapy andtargeted therapy, has significant relief effect on symptoms of fatigue, xerostomia and the like, and can improve life quality of patients. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a LUO LING |4 aut | |
700 | 0 | |a FU LING |4 aut | |
700 | 0 | |a ZHOU JINGZHENG |4 aut | |
700 | 0 | |a MA LIHAI |4 aut | |
700 | 0 | |a ZHENG DANDAN |4 aut | |
700 | 0 | |a TANG HONGQU |4 aut | |
700 | 0 | |a WANG YUHONG |4 aut | |
700 | 0 | |a ZHENG YU |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 15. Sept. |
773 | 1 | 8 | |g year:2020 |g day:15 |g month:09 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72392611/publication/CN111658747A1?q=CN111658747 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2020 |b 15 |c 09 |
951 | |a AR | ||
952 | |j 2020 |b 15 |c 09 |